FindTrial
Sign In

Vitamin D Treatment in Patients With Chronic Hepatitis C

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00804752
Enrollment
Unknown
Registered
2008-12-09
Start date
Unknown
Completion date
Unknown
Last updated
2008-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis C

Keywords

Patients with Chronic Hepatitis C

Brief summary

We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.

Interventions

DRUGAdding vitamin D

Adding 1000IU/Vitamin D daily

DRUGVitamin D

Addition of 1000IU/day Vitamin D

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic Hepatitis C Genotype 1

Exclusion criteria

* Vitamin D intoxication Renal Failure Liver Failure Malignancy

Design outcomes

Primary

MeasureTime frame
To increase the sustained virological responseOne year

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026